Zanidip 10mg 1 Tablet
₱30.75
IMPORTANT NOTICE:
For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff format). After you have placed your order, our pharmacist will be in touch to confirm your order and validate your prescription. Please present the original copy of your prescription upon the arrival of your order.
An item like loose capsule/tablets, ampules, vials, and refrigerated items is not subject for merchandise return or exchange upon completing the purchase.
| Brand Name | ZANIDIP 10MG |
| Generic Name | Lercanidipine |
| Strength | 10mg Tablet |
| Dosage Form | Tablet |
| Class Name | Calcium Channel Blocker (Diydropyridine derivatives) |
| Indication/Usage | Lercanidipine (Zanidip) is indicated for the treatment of mild to moderate essential hypertension. Some individuals, not adequately controlled on a single antihypertensive agent may benefit from the addition of Lercanidipine (Zanidip) with a beta-adrenocaptor blocking drug, a diuretic or an angiotensin converting enzyme inhibitor. |
| Dosage and Administration | The recommended dosage is 10 mg orally, once a day before meals; the dose may be increased to 20 mg depending on the individual patient’s response. Dose titration should be gradual because it may take about 2 weeks before the maximal antihypertensive effect is apparent. In severe hypertension, the dose titration period should be reduced. Use in the elderly Although the pharmacokinetic data and clinical experience suggest that no adjustment of the daily dosage is required, special care should be exercised when initiating treatment in the elderly. Use in children Since there is no clinical experience in patients under the age of 18 years, use in children is not currently recommended. Use in renal or hepatic dysfunction Special care should be exercised when treatment is commenced in patients with renal or hepatic dysfunction. Although the usually recommended dose schedule may be tolerated by these subgroups, an increase in the dose to 20 mg daily must be approached with caution. Lercanidipine (Zanidip) is not recommended for use in patients with severe hepatic or renal dysfunction. |
| Warning and Precautions | Special care should be exercised when Lercanidipine is used in patients with sick sinus syndrome (if a pacemaker is not in situ). Although hemodynamic controlled studies revealed no impairment of ventricular function, care is also required in patients with LV dysfunction. It has been suggested that some short-acting dihydropyridines may be associated with increased cardiovascular risk in patients with ischemic heart disease. Although Lercanidipine is long-acting, caution is required in such patients. Some dihydropyridines may rarely lead to precordial pain or angina pectoris. Very rarely patients with pre-existing angina pectoris may experience increased frequency, duration or severity of these attacks. Isolated cases of myocardial infarction may be observed. |
| Contraindication | Hypersensitivity to any dihydropyridine or any ingredient of the preparation. Lercanidipine (Zanidip) is also contraindicated during pregnancy and lactation; in women of child-bearing potential unless effective contraception is used. In patients with left ventricular outflow tract obstruction, untreated congestive cardiac failure, unstable angina pectoris, severe renal or hepatic dysfunctions or within 1 month of a myocardial infarction. |
| Requires prescription? | Yes |
| Storage Conditions | Store at temperatures not exceeding 30°C, away from direct heat and sunlight |
| Manufacturer | Recordati Industria Chimica E Farmaceutica S.p.A |
| Regulatory Classification | Prescription Drug |
Related Products
Zanidip 20mg 1 Tablet
₱41.50
IMPORTANT NOTICE:For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp,...
